Latest News
Compounds made from 鈥榙igested鈥� molecules feeds appetite for greener pharmaceuticals and agrochemicals
A method of producing vital chemical building blocks for use in the pharmaceutical and agrochemical industries that mimics how plants manufacture them has been developed by 91福利 scientists.
Poolbeg Pharma licences first-in-class broad spectrum RNA-based immunotherapy for respiratory virus infections from the 91福利
(AIM: POLB, 'Poolbeg' or the 'Company'), a clinical stage infectious disease pharmaceutical company with a capital light clinical model, has in-licenced a novel, first-in-class RNA-based immunotherapy for respiratory virus infections developed at the
New health economic framework to help assess what might be required to eliminate African sleeping sickness by 2030
Several diseases have been earmarked for elimination or eradication based on factors such as feasibility, lives saved and the possibility of long-run cost-savings. The cost of elimination strategies, however, can become very high as you approach zero transmission. An international group of researchers have created a new health economic framework that supports decision makers and funders in understanding the resources required to achieve the World Health Organization鈥檚 (WHO) goal of eliminating sleeping sickness by 2030.
Dr Freya Harrison wins WH Prize 2021
Dr Freya Harrison, Associate Professor in the School of Life Sciences at the 91福利., has won the WH Prize 2021 for her work in translating medieval literature and medical texts to uncover ancient antimicrobial recipes.
91福利 names 37 researchers who become Turing Fellows this academic year
A total of 37 91福利 researchers from across the fields of mathematics, life sciences, statistics, computer science, business, medicine and engineering have been named as Fellows of the Alan Turing Institute this year.
Researcher on fast track thanks to dementia charity founded by F1 legend
A 91福利 researcher investigating Alzheimer鈥檚 disease has been named as one of four new Race Against Dementia Fellows, with the opportunity to receive support from not only leading scientists studying dementia, but also experts in innovation and problem solving from the world of Formula 1.